Combination therapy: management of acute myocardial infarction in the new millennium 1 1 Please note the changes made to this article since its first printing: on page 33S, right column, line 17, “TIMI 11B” is now “TIMI 10B.” On page 34S, left column, line 31, the sentence should read “In TIMI-14, the 32% rate of TIMI-3 patency provided by abciximab was shown to be equal to the patency provided by streptokinase.” On page 35S, left column, the last sentence now reads “[A]lthough early benefits of lamifiban therapy were seen in this study, the 30-day primary composite end point was similar between the patients randomized to lamifiban and the patients who received placebo.” Finally, on page 36S, the legends to Figures 2 and 3 have been transposed. Therefore, the legend to Figure 2 now reads “TIMI 3 flow in TIMI-14” and Figure 3 now reads “SPEED: TIMI 3 flow at 60–90 min.”
Titel:
Combination therapy: management of acute myocardial infarction in the new millennium 1 1 Please note the changes made to this article since its first printing: on page 33S, right column, line 17, “TIMI 11B” is now “TIMI 10B.” On page 34S, left column, line 31, the sentence should read “In TIMI-14, the 32% rate of TIMI-3 patency provided by abciximab was shown to be equal to the patency provided by streptokinase.” On page 35S, left column, the last sentence now reads “[A]lthough early benefits of lamifiban therapy were seen in this study, the 30-day primary composite end point was similar between the patients randomized to lamifiban and the patients who received placebo.” Finally, on page 36S, the legends to Figures 2 and 3 have been transposed. Therefore, the legend to Figure 2 now reads “TIMI 3 flow in TIMI-14” and Figure 3 now reads “SPEED: TIMI 3 flow at 60–90 min.”
Tijdschrift beschrijving